Relief Therapeutics Holding AG (RLFTF)

[Biohunter21]

Who actually read the preprint? I honestly haven’t seen any discussion about it. There are two errors, one on page 3 and another on page 5. I’d love to know where it came from because I find it hard to believe they’d let this out mistaking 6 patients for 21. It’s shocking to me that in all the threads here and Yahoo not a single person mentioned this. Does anyone investing here do any due diligence, yet alone read 8 simple pages, I really don’t get it.

Diving into the data is impressive. We have patients with comorbidities, but we don’t know what they are. What we do know about these 21 patients is that they were the sickest of the sick. Probably a 20-30% survival rate. When you’re as ill as these people you don’t just get up and walk out of the hospital, the print makes that clear. Here is the data as of 21 days:

2 perished, one unrelated to COVID. 10 discharged, 8 are still on vents. If half of those on vents survive, we’re in the neighborhood of a 2/3 survival rate amongst the most ill, that’s def at the front of the pack for a treatment. I’m excited for the inhaler trial to start next month, and building on the excitement from their current trials, I would expect them to enroll fast. That’s really where this company can shine, if that works, prevents progression to severe COVID, then big pharma comes in and buys the drug for like $20B.